PL2490779T3 - Sposób zwiększania krystaliczności - Google Patents

Sposób zwiększania krystaliczności

Info

Publication number
PL2490779T3
PL2490779T3 PL10770869T PL10770869T PL2490779T3 PL 2490779 T3 PL2490779 T3 PL 2490779T3 PL 10770869 T PL10770869 T PL 10770869T PL 10770869 T PL10770869 T PL 10770869T PL 2490779 T3 PL2490779 T3 PL 2490779T3
Authority
PL
Poland
Prior art keywords
improving crystallinity
crystallinity
improving
Prior art date
Application number
PL10770869T
Other languages
English (en)
Inventor
Graham Ruecroft
Dipesh Parikh
Original Assignee
Prosonix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prosonix Ltd filed Critical Prosonix Ltd
Publication of PL2490779T3 publication Critical patent/PL2490779T3/pl

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0018—Evaporation of components of the mixture to be separated
    • B01D9/0027—Evaporation of components of the mixture to be separated by means of conveying fluid, e.g. spray-crystallisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D1/00—Evaporating
    • B01D1/16—Evaporating by spraying
    • B01D1/18—Evaporating by spraying to obtain dry solids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0081—Use of vibrations, e.g. ultrasound
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/04—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a gaseous medium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/18—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic using a vibrating apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
PL10770869T 2009-10-21 2010-10-20 Sposób zwiększania krystaliczności PL2490779T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0918431.8A GB0918431D0 (en) 2009-10-21 2009-10-21 Process for improving crystallinity
EP10770869.5A EP2490779B1 (en) 2009-10-21 2010-10-20 Process for improving crystallinity
PCT/GB2010/051762 WO2011048412A1 (en) 2009-10-21 2010-10-20 Process for improving crystallinity

Publications (1)

Publication Number Publication Date
PL2490779T3 true PL2490779T3 (pl) 2016-04-29

Family

ID=41426459

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10770869T PL2490779T3 (pl) 2009-10-21 2010-10-20 Sposób zwiększania krystaliczności

Country Status (11)

Country Link
US (1) US8771744B2 (pl)
EP (2) EP2998007A1 (pl)
DK (1) DK2490779T3 (pl)
ES (1) ES2559935T3 (pl)
GB (1) GB0918431D0 (pl)
HR (1) HRP20160026T1 (pl)
HU (1) HUE025839T2 (pl)
PL (1) PL2490779T3 (pl)
PT (1) PT2490779E (pl)
SI (1) SI2490779T1 (pl)
WO (1) WO2011048412A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012010854A1 (en) * 2010-07-23 2012-01-26 Cipla Limited Inhalation formulations comprising carmoterol in combination with a corticosteroid
US10179139B2 (en) 2010-10-12 2019-01-15 Cipla Limited Pharmaceutical composition
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
MX2015009891A (es) 2013-01-31 2016-03-08 Prosonix Ltd Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion.
GB201301721D0 (en) * 2013-01-31 2013-03-20 Prosonix Ltd Pharmaceutical Preparations
WO2014178891A1 (en) 2013-04-30 2014-11-06 Otitopic Inc. Dry powder formulations and methods of use
CN104138794B (zh) * 2014-08-04 2017-07-18 安徽黄山云乐灵芝有限公司 一种微粒类物料生产过程中的水分离除杂工艺
CZ2015257A3 (cs) 2015-04-16 2016-10-26 Zentiva, K.S. Způsob pro zmenšování velikosti částic bromidu [(3R)-1-(3-fenoxypropyl)chinuklidin-1-ium-3-yl] 2-hydroxy-2,2-bis(2-thienyl)acetátu
KR20230040375A (ko) 2017-09-22 2023-03-22 오티토픽 인코퍼레이티드 스테아르산마그네슘을 갖는 건조 분말 조성물
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation
ES2953293T3 (es) * 2018-08-07 2023-11-10 Norton Waterford Ltd Aplicación de espectroscopia Raman para la fabricación de polvos para inhalación
BR112021012133A8 (pt) * 2018-12-20 2023-04-11 Merck Sharp & Dohme Forma 1 anidra cristalina de 4'-etinil-2-fluoro-2'-desoxiadenosina, forma 4 anidra cristalina de 4'-etinil-2-fluoro-2'-desoxiadenosina, e, composição farmacêutica
TR201916307A1 (tr) * 2019-10-23 2021-05-21 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi İnhalasyon i̇çi̇n kuru toz kompozi̇syonlarinin hazirlanmasina yöneli̇k bi̇r i̇şlem

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468434B (sv) 1987-01-21 1993-01-18 Nobel Kemi Ab Foerfarande foer rening av hns (2,2',4,4',6,6'- hexanitrostilben) och framstaellning av hnsii
GB2337514B (en) 1998-05-22 2000-04-12 Mark Youds Crystalline structure enhancer
AU2002307907B2 (en) * 2001-05-05 2007-03-01 Accentus Plc Formation of small crystals
GB0212626D0 (en) 2002-05-31 2002-07-10 Accentus Plc Production of crystalline ingredients
GB0216700D0 (en) 2002-07-18 2002-08-28 Astrazeneca Ab Process
US7445796B2 (en) * 2002-08-19 2008-11-04 L. Perrigo Company Pharmaceutically active particles of a monomodal particle size distribution and method
US20040138410A1 (en) * 2003-01-14 2004-07-15 The University Of Akron Ultrasound assisted process for increasing the crystallinity of slow crystallizable polymers
WO2004073827A1 (en) 2003-02-21 2004-09-02 The University Of Bath Process for the production of particles
FR2854171B1 (fr) 2003-04-24 2005-06-17 Inst Francais Du Petrole Solide cristallise im-8 de type metallophosphate et son procede de preparation
WO2005089375A2 (en) 2004-03-12 2005-09-29 S.S.C.I., Inc. Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
WO2006090350A1 (en) * 2005-02-28 2006-08-31 Ranbaxy Laboratories Limited A method for sieving pharmaceutical substances
US7602077B2 (en) 2005-05-03 2009-10-13 Magenn Power, Inc. Systems and methods for tethered wind turbines
WO2007075793A2 (en) * 2005-12-21 2007-07-05 S.S.C.I., Inc. Sonication methods for screening and preparing solid forms
GB0705159D0 (en) 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
BRPI0915783A2 (pt) * 2008-07-18 2018-05-22 Prosonix Ltd processo para aumentar a cristalinidade de pelo menos um material sólido, partícula, composição farmacêutica ou agroquímica , e, inalador

Also Published As

Publication number Publication date
SI2490779T1 (sl) 2016-04-29
ES2559935T3 (es) 2016-02-16
HRP20160026T1 (hr) 2016-02-26
EP2998007A1 (en) 2016-03-23
EP2490779A1 (en) 2012-08-29
HUE025839T2 (en) 2016-05-30
US8771744B2 (en) 2014-07-08
WO2011048412A1 (en) 2011-04-28
US20120309729A1 (en) 2012-12-06
PT2490779E (pt) 2016-02-16
DK2490779T3 (en) 2016-01-25
GB0918431D0 (en) 2009-12-09
EP2490779B1 (en) 2015-12-02

Similar Documents

Publication Publication Date Title
IL210729A0 (en) Process for improving crystallinity
PL2490779T3 (pl) Sposób zwiększania krystaliczności
GB0918069D0 (en) Process
GB0901254D0 (en) Process
GB0907879D0 (en) Process
GB0912255D0 (en) Process
GB0905998D0 (en) Process
GB0906191D0 (en) Process
EP2404985A4 (en) PROCESS FOR PRODUCING LIPID
GB0914500D0 (en) Process
GB0901817D0 (en) Process
GB0914572D0 (en) Process
GB0912254D0 (en) Process
GB0915106D0 (en) Process
GB0913318D0 (en) Process
GB0907942D0 (en) Process
GB0902286D0 (en) Process
GB0901816D0 (en) Process
EP2487150A4 (en) PROCESS FOR PRODUCING 2 ALKYLCYCLOALCANONE
GB0918613D0 (en) Process
GB0906031D0 (en) Process
IL215692A0 (en) Process for producing 2-halogeno-6-substituted-4- trifluoromethylpyridine
GB0903956D0 (en) Process
GB0901822D0 (en) Process
GB0915627D0 (en) Process